The pathology Core B functions to centralized tissue acquisition and tracking and provide a laboratory base for tissue processing and biomarker. The core is designed to 1) promote interactions between the project investigators, 2) provide consistent review of histological diagnoses, 4) provide tissue processing for molecular studiers, and 5) interact with external hospitals and clinicians in a unified and productive manner when requesting tissue. To accomplish these goals we: 1. maintain close communication with investigators and staff in individual projects and participate in monthly Project Projects meetings. 2, provide histological review of specimens to assess quantity of tissue and select and process tissue blocks for laboratory analyses. 3. maintain and a computerized tracking system (coordinated with the individual projects by Stephanie Stafford through the Administrative Core) for all tissue blocks submitted for laboratory analyses. For the next grant period, the work of the core will continue to be carried out in Core B under the direction of Dr. Porter, a board certified anatomic pathologist with added quantification in Cytopathology. Diagnostic review of all specimens collected for Projects 1, 2, and 3 will continue to be done by Dr. Porter. Samples will be ranked for molecular studies based on diagnoses and quantify of relevant tissue. Rigorous quality assurance in tissue processing will be carried out to prevent HPV cross- contamination of specimens. The Core will be responsible for performing and coordinating state-of-the-art techniques for tissue dissection and flow cytometric cell purification of CGH studies in Project 3 as needed.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA042792-14A1
Application #
6442273
Study Section
Project Start
1987-04-10
Project End
2006-03-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
14
Fiscal Year
2001
Total Cost
$280,718
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Bao, Xiao; Hanson, Aimee L; Madeleine, Margaret M et al. (2018) HLA and KIR Associations of Cervical Neoplasia. J Infect Dis 218:2006-2015
Leo, Paul J; Madeleine, Margaret M; Wang, Sophia et al. (2017) Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study. PLoS Genet 13:e1006866
Wallace, Nicholas A; Khanal, Sujita; Robinson, Kristin L et al. (2017) High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway. J Virol 91:
Madeleine, Margaret M; Johnson, Lisa G; Doody, David R et al. (2016) Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3). J Low Genit Tract Dis 20:257-60
Hardikar, Sheetal; Johnson, Lisa G; Malkki, Mari et al. (2015) A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers. Gynecol Oncol 139:90-6
Wallace, Nicholas A; Robinson, Kristin; Howie, Heather L et al. (2015) ?-HPV 5 and 8 E6 disrupt homology dependent double strand break repair by attenuating BRCA1 and BRCA2 expression and foci formation. PLoS Pathog 11:e1004687
Galloway, Denise A; Laimins, Laimonis A (2015) Human papillomaviruses: shared and distinct pathways for pathogenesis. Curr Opin Virol 14:87-92
Safaeian, Mahboobeh; Johnson, Lisa G; Yu, Kai et al. (2014) Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma. Front Oncol 4:119
Madeleine, Margaret M; Carter, Joseph J; Johnson, Lisa G et al. (2014) Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, and TMC6/8 (EVER1/2) variants. Cancer Med 3:1440-7
Wallace, Nicholas A; Galloway, Denise A (2014) Manipulation of cellular DNA damage repair machinery facilitates propagation of human papillomaviruses. Semin Cancer Biol 26:30-42

Showing the most recent 10 out of 127 publications